RNT Stock Overview
Develops and commercializes medical isotopes in Poland. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Private Rented Sector S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł3.70 |
52 Week High | zł11.60 |
52 Week Low | zł2.00 |
Beta | 2.47 |
11 Month Change | 20.13% |
3 Month Change | 29.37% |
1 Year Change | 15.63% |
33 Year Change | 95.77% |
5 Year Change | 117.65% |
Change since IPO | -97.90% |
Recent News & Updates
Recent updates
Shareholder Returns
RNT | PL Medical Equipment | PL Market | |
---|---|---|---|
7D | 20.1% | -3.9% | -0.2% |
1Y | 15.6% | -16.0% | 0.3% |
Return vs Industry: RNT exceeded the Polish Medical Equipment industry which returned -16% over the past year.
Return vs Market: RNT exceeded the Polish Market which returned 0.3% over the past year.
Price Volatility
RNT volatility | |
---|---|
RNT Average Weekly Movement | 17.9% |
Medical Equipment Industry Average Movement | 6.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in PL Market | 8.4% |
10% least volatile stocks in PL Market | 2.9% |
Stable Share Price: RNT's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: RNT's weekly volatility has decreased from 25% to 18% over the past year, but is still higher than 75% of Polish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Jakuba Suchanek | www.medical-isotope.com |
Private Rented Sector S.A. develops and commercializes medical isotopes in Poland. The company offers Technetium-99m, a medical isotope for deployment using standard research and commercial reactors. The company was formerly known as Perma-Fix Medical S.A. and changed its name to Private Rented Sector S.A. in March 2023.
Private Rented Sector S.A. Fundamentals Summary
RNT fundamental statistics | |
---|---|
Market cap | zł4.89m |
Earnings (TTM) | -zł67.13k |
Revenue (TTM) | zł100.00k |
48.9x
P/S Ratio-72.8x
P/E RatioIs RNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RNT income statement (TTM) | |
---|---|
Revenue | zł100.00k |
Cost of Revenue | zł0 |
Gross Profit | zł100.00k |
Other Expenses | zł167.13k |
Earnings | -zł67.13k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.051 |
Gross Margin | 100.00% |
Net Profit Margin | -67.13% |
Debt/Equity Ratio | 0% |
How did RNT perform over the long term?
See historical performance and comparison